CClinicalTrials.gg
Status unknownNCT04219384CIRCAUpdated Oct 5, 2020

Critical Illness Related Cardiac Arrest (CIRCA)

An observational study in Critical Illness, sponsored by Intensive Care National Audit & Research Centre. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-10-05.

Sponsored by Intensive Care National Audit & Research Centre · Observational

The sponsor has not verified this record recently (last verified Oct 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,800
Ages
18 Years and older
Sex
All
01

Study summary

CIRCA aims to determine the incidence and outcomes of in-hospital cardiac arrest (IHCA) in UK intensive care units (ICUs) and explore associated risk factors with ICU and hospital survival and quality of survival following hospital discharge.

Read the detailed description

Cardiac arrest is often categorised by location, out-of-hospital or in-hospital (IHCA), as there are important differences in population characteristics and aetiology. The National Cardiac Arrest Audit (NCAA) was established to audit resuscitation teams in response to IHCA, and collects information about patient characteristics, resuscitation processes, and patient outcomes. However, it does not audit IHCAs that are not attended by the resuscitation team.

Critically ill patients managed in ICUs are experiencing failure of one or more organs and therefore more intensive and invasive therapies are needed to support these failing organs. As a result, ICUs have higher nursing and medical staffing ratios, and monitoring is usually continuous. Moreover, the skill mix of the multidisciplinary team is geared to advanced life support. Thus, the risk of cardiac arrest occurring, the involvement (or not) of the resuscitation team, and the probability of return of spontaneous circulation are all likely to be different to other IHCAs.

Accurate data on cardiac arrests in ICU are lacking and the investigators do not know how many IHCA occur in ICU in the UK, nor is the impact of an IHCA in ICU on outcome known. In addition, it is not known if these IHCAs in ICUs represent an unavoidable consequence of critical illness or, more importantly, whether they can be predicted and/or prevented.

CIRCA is a prospective, multi-centre observational cohort study nested in the Case Mix Programme (CMP) and NCAA national clinical audits. The investigators aim to determine the incidence and outcomes of IHCA in UK ICUs and explore associated risk factors with ICU and hospital survival and quality of survival following hospital discharge.

02

Conditions studied

  • Critical Illness

Keywords

  • Critical Illness Related Cardiac Arrest
03

In context

Heart Arrest

965 studies on the registry are indexed under Heart Arrest; 226 are open to participants now.

This study's planned enrollment of 1,800 is above the median of 200 across 382 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Intensive Care National Audit & Research Centre is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Adults having cardiac arrest (defined as receipt of chest compressions and/or defibrillation) after admission to an Intensive Care Unit (ICU) participating in the Case Mix Programme in a hospital participating in the National Cardiac Arrest Audit

Inclusion criteria

  1. Age 18 years old or more; and either
  2. Cardiac arrest (defined as receipt of chest compressions or defibrillation) occurring while in-hospital and within intensive care (defined as either ICU, HDU or combined ICU/HDU); or
  3. Family member of a patient surviving to discharge from intensive care after a cardiac arrest within ICU

Exclusion criteria

Exclusion Criteria:

There are no exclusion criteria

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,800 participants (estimated)
Patient registry
No

Groups and cohorts

  • Critical-illness related cardiac arrest (CIRCA)

    Those experiencing a critical illness-related cardiac arrest in a participating adult, general ICU

06

What researchers measure

Primary outcomes

  1. Incidence

    Incidence of critical illness related cardiac arrest

    Time frame: Up to 12 months

Secondary outcomes

  1. Subsequent incidence of in-hospital cardiac arrest

    Subsequent incidence of in-hospital cardiac arrest obtained through data linkage to the National Cardiac Arrest Audit

    Time frame: Up to 12 months

  2. Survival status at hospital discharge

    Survival status at hospital discharge obtained from data linkage to the Case Mix Programme

    Time frame: Up to 12 months

  3. Survival status at 12 months

    Survival status at 12 months obtained from data linkage to NHS Digital

    Time frame: 12 months

  4. Patient quality of life measured through EQ-5D-5L questionnaire completion at 3 months

    Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 3 months following critical illness related cardiac arrest

    Time frame: 3 months

  5. Patient quality of life measured through EQ-5D-5L questionnaire completion at 6 months

    Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 6 months following critical illness related cardiac arrest

    Time frame: 6 months

  6. Patient quality of life measured through EQ-5D-5L questionnaire completion at 12 months

    Patient quality of life measured through completion of EuroQol 5 Dimension (5 level) questionnaire at 12 months following critical illness related cardiac arrest

    Time frame: 12 months

  7. Patient quality of life measured through IQCODE questionnaire completion at 3 months

    Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 3 months following critical illness related cardiac arrest

    Time frame: 3 months

  8. Patient quality of life measured through IQCODE questionnaire completion at 6 months

    Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 6 months following critical illness related cardiac arrest

    Time frame: 6 months

  9. Patient quality of life measured through IQCODE questionnaire completion at 12 months

    Patient quality of life measured through completion of Informant Questionnaire on Cognitive Decline in the Elderly questionnaire at 12 months following critical illness related cardiac arrest

    Time frame: 12 months

  10. Family member quality of life measured through FROM-16 questionnaire completion at 3 months

    Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 3 months following patient arrest

    Time frame: 3 months

  11. Family member quality of life measured through FROM-16 questionnaire completion at 6 months

    Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 6 months following patient arrest

    Time frame: 6 months

  12. Family member quality of life measured through FROM-16 questionnaire completion at 12 months

    Quality of life of family member of patients surviving critical illness related cardiac arrest measured through completion of Family Reported Outcome Measures 16 questionnaire at 12 months following patient arrest

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Intensive Care National Audit & Research Centre
    London, WC1V 6AZ, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — An anonymised study dataset will be available from ICNARC on request to the Chief Investigator, subject to any necessary approvals

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04219384
Lead sponsor
Intensive Care National Audit & Research Centre
Collaborators
North Bristol NHS Trust
Responsible party
Sponsor
First posted
Jan 7, 2020
Start date
Jan 27, 2020
Primary completion
Jun 2021 (estimated)
Completion
Jul 2022 (estimated)
Last update
Oct 5, 2020

Study contacts

Doug Gould
Contact
doug.gould@icnarc.org
02072699277
Robert Darnell
Contact
robert.darnell@icnarc.org
02072699277
Matt Thomas, MD
principal investigator · North Bristol NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion